rs1799922
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001385125.1(OPN1SW):āc.357A>Cā(p.Gly119Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.364 in 1,613,548 control chromosomes in the GnomAD database, including 114,691 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.30 ( 7853 hom., cov: 32)
Exomes š: 0.37 ( 106838 hom. )
Consequence
OPN1SW
NM_001385125.1 synonymous
NM_001385125.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.513
Genes affected
OPN1SW (HGNC:1012): (opsin 1, short wave sensitive) This gene belongs to the G-protein coupled receptor 1 family, opsin subfamily. It encodes the blue cone pigment gene which is one of three types of cone photoreceptors responsible for normal color vision. Defects in this gene are the cause of tritan color blindness (tritanopia). Affected individuals lack blue and yellow sensory mechanisms while retaining those for red and green. Defective blue vision is characteristic. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 7-128775141-T-G is Benign according to our data. Variant chr7-128775141-T-G is described in ClinVar as [Benign]. Clinvar id is 1169097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-128775141-T-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.513 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.402 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPN1SW | NM_001385125.1 | c.357A>C | p.Gly119Gly | synonymous_variant | 2/5 | ENST00000249389.3 | NP_001372054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPN1SW | ENST00000249389.3 | c.357A>C | p.Gly119Gly | synonymous_variant | 2/5 | 1 | NM_001385125.1 | ENSP00000249389.3 |
Frequencies
GnomAD3 genomes AF: 0.296 AC: 45006AN: 152004Hom.: 7849 Cov.: 32
GnomAD3 genomes
AF:
AC:
45006
AN:
152004
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.301 AC: 75425AN: 250374Hom.: 13024 AF XY: 0.309 AC XY: 41810AN XY: 135328
GnomAD3 exomes
AF:
AC:
75425
AN:
250374
Hom.:
AF XY:
AC XY:
41810
AN XY:
135328
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.371 AC: 542730AN: 1461426Hom.: 106838 Cov.: 46 AF XY: 0.368 AC XY: 267793AN XY: 726972
GnomAD4 exome
AF:
AC:
542730
AN:
1461426
Hom.:
Cov.:
46
AF XY:
AC XY:
267793
AN XY:
726972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.296 AC: 45008AN: 152122Hom.: 7853 Cov.: 32 AF XY: 0.290 AC XY: 21595AN XY: 74366
GnomAD4 genome
AF:
AC:
45008
AN:
152122
Hom.:
Cov.:
32
AF XY:
AC XY:
21595
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
443
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Blue color blindness Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
OPN1SW-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at